Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a setback for Argenx, Lilly suits over copycat versions of an obesity drug, and more news.. statnews.com/pharmalot/20... #pharma #obesity #Argenx #Teva #Viatris #Lilly #DrReddys

#argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2 billion acquisition of Forte Biosciences, will move into phase 3 development for #coeliac disease after showing efficacy in a mid-stage trial.

buff.ly/t2xcoTN

BIOTECH · Argenx halts Vyvgart trial in Sjögren's, shares fall 14%

The biotech stopped a late-stage study after an independent panel found the drug unlikely to beat a placebo, erasing a hoped-for expansion.

Read the full story →

#Biotech #Argenx #TheDailyFathom

Investigation Alert: argenx Faces Scrutiny Following Major Trial Discontinuation #None #VYVGART #argenx #SueWallSt

Halozyme Strengthens Global Partnership with argenx to Boost Subcutaneous Drug Delivery #USA #San_Diego #Halozyme #ENHANZE #argenx